We suggest against using IV hydrocortisone to treat septic shock patients if adequate fluid resuscitation and vasopressor therapy are able to restore hemodynamic stability. If this is not achievable, ...

Prolonged infusion of beta-lactam antibiotics for sepsis or septic shock tended to improve mortality compared with conventional intermittent infusion in the BLING III trial, and a meta-analysis ...

Vasopressin caught fire as an adjunct vasopressor for sepsis about 20 years ago. The rationale was that septic patients are vasopressin deficient, at least relatively, and they require exogenous ...

With more than 1 million American dying from sepsis annually, providers follow a set of protocols to mitigate a patient’s risk of sepsis. JAMA delves into the updated guidelines, titled Surviving ...

A study published in BMC Infectious Diseases has found that older patients with sepsis have lower 28-day mortality when blood pressure is maintained within an optimal range. Current ...

Sepsis, a leading cause of death worldwide, demands a shift from generalized treatment to personalized, predictive, and technology-enabled strategies to improve outcomes globally Sepsis is a ...

Both the diagnosis and management of infectious diseases in hospitalized patients remain prominent clinical challenges and are associated with a substantial financial burden for healthcare systems.

Critically ill sepsis patients did not fare better with prolonged infusions of meropenem compared with intermittent infusions of the beta-lactam antibiotic, a randomized trial showed. Among over 600 ...